Impact of T. vaginalis infection on innate immune responses and reproductive outcome

Journal of Reproductive Immunology

Volumn 83, Issue 1-2, 2009, Pages 185-189

  Fichorova, Raina N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokines; Galectins; Human vaginal epithelial cells; Lipophosphoglycan; Trichomonas vaginalis

Indexed keywords

GALECTIN 1; GALECTIN 3; LIPOPHOSPHOGLYCAN; METRONIDAZOLE;

ARTICLE; CLINICAL FEATURE; DISEASE MODEL; EPITHELIUM CELL; HUMAN; INFLAMMATION; INNATE IMMUNITY; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; NONHUMAN; PANCREATITIS; PREGNANCY; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPRODUCTION; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

COMORBIDITY; ENDOMETRITIS; FEMALE; HUMANS; IMMUNITY, INNATE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTION; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; UTERINE CERVICAL NEOPLASMS;

EID: 70450223320     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.08.007     Document Type: Article

References (49)

1. Al-Mohammed H.I., and Hussein E.M. Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients. J. Egypt Soc. Parasitol. 36 (2006) 763-777
2. Alderete J.F., Kasmala L., Metcalfe E., and Garza G.E. Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants. Infect. Immun. 53 (1986) 285-293
3. Bastida-Corcuera F.D., Okumura C.Y., Colocoussi A., and Johnson P.J. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot. Cell 4 (2005) 1951-1958
4. Benchimol M., de Andrade Rosa I., da Silva Fontes R., and Burla Dias A.J. Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction. Parasitol. Res. 102 (2008) 597-604
5. Caliendo A.M., Jordan J.A., Green A.M., Ingersoll J., Diclemente R.J., and Wingood G.M. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol. 13 (2005) 145-150
6. Carlton J.M., Hirt R.P., Silva J.C., Delcher A.L., Schatz M., Zhao Q., et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315 (2007) 207-212
7. Cauci S., and Culhane J.F. Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast. Am. J. Obstet. Gynecol. 196, 133 (2007) e131-137
8. Chang J.-H., Park J.-Y., and Kim S.-K. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells. Immunology 118 (2006) 164-170
9. Chang J.H., Kim S.K., Choi I.H., Lee S.K., Morio T., and Chang E.J. Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation. Int. J. Biochem. Cell Biol. 38 (2006) 638-647
10. Chang J.H., Ryang Y.S., Morio T., Lee S.K., and Chang E.J. Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-kappaB activation. Mol. Cells 18 (2004) 177-185
11. Draper D., Donohoe W., Mortimer L., and Heine R.P. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J. Infect. Dis. 178 (1998) 815-819
12. Fichorova R.N., Rheinwald J.G., and Anderson D.J. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57 (1997) 847-855
13. Fichorova R.N., Trifonova R.T., Gilbert R.O., Costello C.E., Hayes G.R., Lucas J.J., et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect. Immun. 74 (2006) 5773-5779
14. Fichorova R.N., Trifonova R.T., and Singh B.N. T. vaginalis LPG regulates cytokine responses via binding galectins on human vaginal epithelial cells. Microbicides (2008). New Delhi, India www.microbicides2008.com
15. Fogel S., Guittaut M., Legrand A., Monsigny M., and Hebert E. The tat protein of HIV-1 induces galectin-3 expression. Glycobiology 9 (1999) 383-387
16. Huang K.-Y., Chien K.-Y., Lin Y.-C., Hsu W.-M., Fong I.K., Huang P.-J., et al. A proteome reference map of Trichomonas vaginalis. Parasitol. Res. 104 (2009) 927-933
17. Johnson L.F., Coetzee D.J., and Dorrington R.E. Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm. Infect. 81 (2005) 287-293
18. Kang J.H., Song H.O., Ryu J.S., Shin M.H., Kim J.M., Cho Y.S., et al. Trichomonas vaginalis promotes apoptosis of human neutrophils by activating caspase-3 and reducing Mcl-1 expression. Parasite Immunol. 28 (2006) 439-446
19. Kaur S., Khurana S., Bagga R., Wanchu A., and Malla N. Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis. Parasitol. Res. 103 (2008) 305-312
20. Kucknoor A., Mundodi V., and Alderete J.F. Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol. 7 (2005) 887-897
21. Kucknoor A.S., Mundodi V., and Alderete J.F. Adherence to human vaginal epithelial cells signals for increased expression of Trichomonas vaginalis genes. Infect. Immun. 73 (2005) 6472-6478
22. Kucknoor A.S., Mundodi V., and Alderete J.F. The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol. 9 (2007) 2586-2597
23. Lanteri M., Giordanengo V., Hiraoka N., Fuzibet J.-G., Auberger P., Fukuda M., et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 13 (2003) 909-918
24. Malla N., Yadav M., and Gupta I. Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women. Parasite Immunol. 29 (2007) 101-105
25. McClelland R.S. Trichomonas vaginalis infection: can we afford to do nothing?. J. Infect. Dis. 197 (2008) 487-489
26. Mercier S., St-Pierre C., Pelletier I., Ouellet M., Tremblay M.J., and Sato S. Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 371 (2008) 121-129
27. Nieminen J., St-Pierre C., Bhaumik P., Poirier F., and Sato S. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J. Immunol. 180 (2008) 2466-2473
28. Okumura C.Y., Baum L.G., and Johnson P.J. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell Microbiol. 10 (2008) 2078-2090
29. Okun N., Gronau K.A., and Hannah M.E. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet. Gynecol. 105 (2005) 857-868
30. Rabinovich G.A., and Gruppi A. Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease. Parasite Immunol. 27 (2005) 103-114
31. Ryu J.S., Kang J.H., Jung S.Y., Shin M.H., Kim J.M., Park H., et al. Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect. Immun. 72 (2004) 1326-1332
32. Sena A.C., Miller W.C., Hobbs M.M., Schwebke J.R., Leone P.A., Swygard H., et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin. Infect. Dis. 44 (2007) 13-22
33. Shafir S.C., Sorvillo F.J., and Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin. Microbiol. Rev. 22 (2009) 37-45
34. Shaio M.F., Lin P.R., Lee C.S., Hou S.C., Tang P., and Yang K.D. A novel neutrophil-activating factor released by Trichomonas vaginalis. Infect. Immun. 60 (1992) 4475-4482
35. Shaio M.F., Lin P.R., Liu J.Y., and Yang K.D. Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation. Infect. Immun. 63 (1995) 3864-3870
36. Simhan H.N., Anderson B.L., Krohn M.A., Heine R.P., Martinez de Tejada B., Landers D.V., et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am. J. Obstet. Gynecol. 196, 59 (2007) e51-55
37. Singh B.N., Hayes G.R., Lucas J.J., Sommer U., Viseux N., Mirgorodskaya E., et al. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconjugate J. 26 (2009) 3-17
38. Singh B.N., Lucas J.J., and Fichorova R.N. Trichomonas vaginalis: pathobiology and pathogenesis. In: Khan N.A., et al. (Ed). Emerging Protozoan Pathogens (2007), Taylor & Francis Group, London, UK 411-455
39. Smith L.M., Wang M., Zangwill K., and Yeh S. Trichomonas vaginalis infection in a premature newborn. J. Perinatol. 22 (2002) 502-503
40. Sommer U., Costello C.E., Hayes G.R., Beach D.H., Gilbert R.O., Lucas J.J., et al. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J. Biol. Chem. 280 (2005) 23853-23860
41. Than N.G., Erez O., Wildman D.E., Tarca A.L., Edwin S.S., Abbas A., et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J. Matern. Fetal Neonat. Med. 21 (2008) 429-442
42. Than N.G., Kim S.S., Abbas A., Han Y.M., Hotra J., Tarca A.L., et al. Chorioamnionitis and increased galectin-1 expression in PPROM-an anti-inflammatory response in the fetal membranes?. Am. J. Reprod. Immunol. 60 (2008) 298-311
43. Van Der Pol B., Williams J.A., Orr D.P., Batteiger B.E., and Fortenberry J.D. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J. Infect. Dis. 192 (2005) 2039-2044
44. Vanacova S., Liston D.R., Tachezy J., and Johnson P.J. Molecular biology of the amitochondriate parasites, Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. Int. J. Parasitol. 33 (2003) 235-255
45. Weinstock H., Berman S., and Cates Jr. W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sex Reprod. Health 36 (2004) 6-10
46. Yadav M., Dubey M.L., Gupta I., and Malla N. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis infected women. Parasite Immunol. 29 (2007) 359-365
47. Yadav M., Gupta I., and Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunol. 27 (2005) 461-467
48. Zariffard M.R., Harwani S., Novak R.M., Graham P.J., Ji X., and Spear G.T. Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin. Immunol. 111 (2004) 103-107
49. Zubácová Z., Cimburek Z., and Tachezy J. Comparative analysis of trichomonad genome sizes and karyotypes. Mol. Biochem. Parasitol. 161 (2008) 49-54